pubs.acs.org/joc
statins, used for lowering blood cholesterol (Figure 1).3
Triethanolamine-Mediated Palladium-Catalyzed
Regioselective C-2 Direct Arylation
of Free NH-Pyrroles
Diaryl-1H-pyrroles 2 and 3 have been identified as p38
mitogen-activated protein (MAP) kinases4 and cyclooxygen-
ase-2 (COX-2)-selective inhibitors,5 respectively (Figure 1).
Farnaz Jafarpour,* Soraya Rahiminejadan, and
Hamideh Hazrati
School of Chemistry, University College of Science,
University of Tehran, P.O. Box 14155-6455, Tehran, Iran
Received December 31, 2009
FIGURE 1. Biologically active compounds containing the 2-aryl-
pyrrole framework.
Furthermore, the pyridyl diaryl-1H-pyrrole 4 has been
reported to be a glucagon receptor antagonist, which is able
to block glucose production (Figure 1).6 Thus, several syn-
thetic challenges have stimulated the development of milder
and more efficient methods for the synthesis of these hetero-
cyclic compounds. Direct functionalization of desired scaf-
fold through regioselective C-H bond activation in the
presence of a reactive N-H functionality provides an effi-
cient cost-effective, environmentally attractive and atom-
economical entry to these compounds as it eliminates
the need for introducing protecting groups and reactive
An atom-economical phosphane-free palladium-catalyzed
direct C-2 arylation of unactivated free NH-pyrroles is
devised. This method provides a straithforward route
to a wide variety of substituted 2-aryl-1H-pyrroles from
readily accessible starting materials. Iodoarenes bearing
electron-withdrawing and electron-donating substituents
are tolerated under the presented reaction conditions.
The scope of the reaction is also expanded to N-aryl
and -alkylpyrroles albeit in lower yields.
(4) de Laszlo, S. E.; Visco, D.; Agarwai, L.; Chang, L.; Chen, J.; Croft, G.;
ꢀ
Forsyth, A.; Fletcher, D.; Frantz, B.; Hacker, C.; Hanlon, W.; Harper, C.;
Kostura, M.; Li, B.; Luell, S.; MacCoss, M.; Mantlo, N.; O’Neill, E. A.;
Orevillo, C.; Pang, M.; Parsons, J.; Rolando, A.; Sahly, Y.; Sidler, K.;
Widmer, W. R.; O’Keefe, S. Bioorg. Med. Chem. Lett. 1998, 8, 2689.
(5) Wilkerson, W. W.; Copeland, R. A.; Covington, M.; Trzaskos, J. M.
J. Med. Chem. 1995, 38, 3895.
(6) de Laszlo, S. E.; Hacker, C.; Li, B.; Kim, D.; MacCoss, M.; Mantlo,
N.; Pivnichny, J. V.; Colwell, L.; Koch, G. E.; Cascieri, M. A.; Hagmann, W.
K. Bioorg. Med. Chem. Lett. 1999, 9, 641.
Nitrogen-containing biaryls have attracted considerable
attention as they are common motifs in biologically active
products.1 2-Arylpyrroles continue to attract the attention of
synthetic organic chemists as they are integral components of
natural products and pharmaceuticals. Several synthetic
2-arylpyrrole derivatives have been shown to possess inter-
esting biological and biomedical properties.2 For instance,
atorvastatin 1, is a member of the drug class known as
(7) (a) Metal-Catalyzed Cross-Coupling Reactions; Diederich, F., Stang,
P. J., Eds.; Wiley-VCH: Weinheim, 1998. (b) Metal-Catalyzed Cross-Coupling
Reactions, 2nd ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: Weinheim,
2004. (c) Cross-Coupling Reactions. A Practical Guide; Miyaura, N., Ed.;
Springer: Berlin, 2002. (d) Handbook of Organopalladium Chemistry for
Organic Synthesis; Negishi, E.-I., Ed.; John Wiley & Sons: New York, 2002.
For recent reviews on direct arylation of pyrroles, see: (e) Alberico, D.; Scott,
M. E.; Lautens, M. Chem. Rev. 2007, 107, 174. (f) Seregin, I. V.; Gevorgyan, V.
J. Chem. Soc., Chem. Rev. 2007, 36, 1173. (g) Campeau, L.-C.; Stuart, D. R.;
Fagnou, K. Aldrichim. Acta 2007, 40, 35. (h) Joucla, L.; Djakovitch, L. Adv.
Synth. Catal. 2009, 351, 673. (i) Chen, X.; Engle, K. M.; Wang, D.-H.; Yu, J.-Q.
Angew. Chem., Int. Ed. 2009, 48, 5094. For recent examples of direct arylation of
pyrroles, see: (j) Blaszykowski, C.; Aktoudianakis, E.; Bressy, C.; Alberico, D.;
Lautens, M. Org. Lett. 2006, 8, 2043. (k) Toure, B. B.; Lane, B. S.; Sames, D.
Org. Lett. 2006, 8, 1979. (l) Stuart, D. R.; Villemure, E.; Fagnou, K. J. Am.
Chem. Soc. 2007, 129, 12072. (m) Yang, S.-D.; Sun, C.-L.; Fang, Z.; Li, B.-J.; Li,
Y.-Z.; Shi, Z.-J. Angew. Chem., Int. Ed. 2007, 47, 1473. (n) Blaszykowski, C.;
Aktoudianakis, E.; Alberico, D.; Bressy, C.; Hulcoop, D. G.; Jafarpour, F.;
Joushaghani, A.; Laleu, B.; Lautens, M. J. Org. Chem. 2008, 73, 1888. (o)
Gracia, S.; Cazorla, C.; Metay, E.; Pellet-Rostaing, S.; Lemaire, M. J. Org. Chem.
2009, 74, 3160. (p) Fall, Y.; Doucet, H.; Santelli, M. ChemSusChem 2009, 2, 153.
(1) (a) Chimenti, F.; Maccioni, E.; Secci, D.; Bolasco, A.; Chimenti, P.;
Granese, A.; Carradori, S.; Alcaro, S.; Ortuso, F.; Yanez, M.; Orallo, F.;
Cirilli, R.; Ferretti, R.; La Torre, F. J. Med. Chem. 2008, 51, 4874. (b)
Goodacre, S. C.; Street, L. J.; Hallett, D. J.; Crawforth, J. M.; Kelly, S.;
Owens, A. P.; Blackaby, W. P.; Lewis, R. T.; Stanley, J.; Smith, A. J.; Ferris,
P.; Sohal, B.; Cook, S. M.; Pike, A.; Brown, N.; Wafford, K. A.; Marshall,
G.; Castro, J. L.; Atack, J. R. J. Med. Chem. 2006, 49, 35. (c) Armistead, D. M.;
Badia, M. C.; Bemis, G. W.; Bethiel, R. S.; Frank, C. A.; Novak, P. M.; Ronkin,
S. M.; Saunders, J. O. U.S. Patent 6 054 472, 1997. (d) Dale, D. J.; Dunn, P. J.;
Golightly, C.; Hughes, M. L.; Levett, P. C.; Pearce, A. K.; Searle, P. M.; Ward, G.;
Wood, A. S. Org. Process Res. Dev. 2000, 4, 17. (e) Carpenter, A. J.; Cooper, J. P.;
Handlon, A. L.; Hertzog, D. L.; Hyman, C. E.; Guo, Y. C.; Speake, J. D.; Witty,
D. R. U.S. Patent 7 285 557, 2003. (f) Cheng, Y.; Albrecht, B. K.; Brown, J.;
Buchanan, J. L.; Buckner, W. H.; DiMauro, E. F.; Emkey, R.; Fremeau, R. T.;
Harmange, J.-C.; Hoffman, B. J.; Huang, L.; Huang, M.; Lee, J. H.; Lin, F.-F.;
Martin, M. W.; Nguyen, H. Q.; Patel, V. F.; Tomlinson, S. A.; White, R. D.; Xia, X.;
Hitchcock, S. A. J. Med. Chem. 2008, 51, 5019.
ꢀ
(q) Roger, J.; Doucet, H. Adv. Synth. Catal. 2009, 351, 1977. (r) Liegault, B.;
(2) Bellinaa, F.; Rossi, R. Tetrahedron 2006, 62, 7213 and references cited
therein.
(3) Chong, P. H.; Seeger, J. D. Pharmacotherapy 1997, 17, 1157.
Lapointe, D.; Caron, L.; Vlassova, A.; Fagnou, K. J. Org. Chem. 2009, 74, 1826.
(s) Gryko, D. T.; Vakuliuk, O.; Gryko, D.; Koszarna, B. J. Org. Chem. 2009, 74,
9517.
DOI: 10.1021/jo902739n
r
Published on Web 04/12/2010
J. Org. Chem. 2010, 75, 3109–3112 3109
2010 American Chemical Society